Aurobindo Pharma MD N Govindarajan steps down
New Delhi: Drug firm Aurobindo Pharma on Friday said N Govindarajan has tendered his resignation as the managing director and a director on the company's board due to personal reasons."His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the services of the company effective from the close of business on December...
New Delhi: Drug firm Aurobindo Pharma on Friday said N Govindarajan has tendered his resignation as the managing director and a director on the company's board due to personal reasons.
"His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the services of the company effective from the close of business on December 31, 2021," Aurobindo Pharma said in a regulatory filing.
Also Read:Aurobindo Pharma arm submits first biosimilar filing with EMA
"The board has further taken note of the appointment of P Yugandhar as the chief executive officer of Eugia Pharma Specialities Ltd, a wholly-owned subsidiary of the company focused on generic injectables and oncology business," Aurobindo Pharma said.
Also Read:Five firms including Cadila, Aurobindo Pharma in race to buy bankrupt Sterling Biotech
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd